Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma | NEJM – nejm.org October 21, 2023
Delcath Systems, Inc. Announces FDA Approval of HEPZATO KIT™ for the Treatment of Adult Patients with Unresectable Hepatic-Dominant Metastatic Uveal Melanoma – PR Newswire August 15, 2023
Opdivo (nivolumab) in Combination with Cisplatin-Based Chemotherapy Shows Overall Survival and Progression-Free Survival Benefit for Cisplatin-Eligible Patients with Unresectable or Metastatic Urothelial Carcinoma in the Phase 3 CheckMate -901 Trial – Bristol-Myers Squibb July 11, 2023
Promising Phase 2 Trial Results for Pembrolizumab in Metastatic Brain Cancer – Neuroscience News June 2, 2023
G1 Therapeutics Announces Top Line Results from Pivotal Phase 3 Trial of Trilaciclib in Patients Receiving Triplet Therapy with FOLFOXIRI + Bevacizumab for Metastatic Colorectal Cancer (CRC) (PRESERVE 1) – Yahoo Finance February 13, 2023
Mother-of-three dies nine days after Stage Four Metastatic Melanoma diagnosis December 24, 2022December 24, 2022
Scientists find novel cell based therapy to treat metastatic melanoma September 11, 2022September 11, 2022
Gilead’s Trodelvy scores ‘surprise’ OS win in metastatic breast cancer, but data will wait for an upcoming conference – Endpoints News August 16, 2022August 16, 2022